Patrys Ltd (ASX:PAB) has been granted a trading halt by the ASX this morning, pending details relating to managing its continuous disclosure obligations.
Patrys currently has a pipeline of anti-cancer antibodies for both internal development and as partnering opportunities.
The halt will remain in place until the opening of trade on Monday 15th January 2018, or earlier if an announcement is made to the market.